Altered extracellular matrix–related pathways accelerate the transition from normal to prefibroid myometrium in Black women - 22/08/24
, Ayman Al-Hendy, MD, PhD a, ⁎ 
Abstract |
Background |
Black women experience a disproportionate impact of uterine fibroids compared to White women, including earlier diagnosis, higher frequency, and more severe symptoms. The etiology underlying this racial disparity remains elusive.
Objective |
The aim of this study was to evaluate the molecular differences in normal myometrium (fibroid-free uteri) and at-risk myometrium (fibroid-containing uteri) tissues in Black and White women.
Study Design |
We conducted whole-genome RNA-seq on normal and at-risk myometrium tissues obtained from both self-identified Black and White women (not Hispanic or Latino) to determine global gene expression profiles and to conduct enriched pathway analyses (n=3 per group). We initially assessed the differences within the same type of tissue (normal or at-risk myometrium) between races. Subsequently, we analyzed the transcriptome of normal myometrium compared to at-risk myometrium in each race and determined the differences between them. We validated our findings through real-time PCR (sample size range=5–12), western blot (sample size range=5–6), and immunohistochemistry techniques (sample size range=9–16).
Results |
The transcriptomic analysis revealed distinct profiles between Black and White women in normal and at-risk myometrium tissues. Interestingly, genes and pathways related to extracellular matrix and mechanosensing were more enriched in normal myometrium from Black than White women. Transcription factor enrichment analysis detected greater activity of the serum response transcription factor positional motif in normal myometrium from Black compared to White women. Furthermore, we observed increased expression levels of myocardin-related transcription factor-serum response factor and the serum response factor in the same comparison. In addition, we noted increased expression of both mRNA and protein levels of vinculin, a target gene of the serum response factor, in normal myometrium tissues from Black women as compared to White women. Importantly, the transcriptomic profile of normal to at-risk myometrium conversion differs between Black and White women. Specifically, we observed that extracellular matrix–related pathways are involved in the transition from normal to at-risk myometrium and that these processes are exacerbated in Black women. We found increased levels of Tenascin C, type I collagen alpha 1 chain, fibronectin, and phospho-p38 MAPK (Thr180/Tyr182, active) protein levels in at-risk over normal myometrium tissues from Black women, whereas such differences were not observed in samples from White women.
Conclusion |
These findings indicate that the racial disparities in uterine fibroids may be attributed to heightened production of extracellular matrix in the myometrium in Black women, even before the tumors appear. Future research is needed to understand early life determinants of the observed racial differences.
Le texte complet de cet article est disponible en PDF.Key words : at-risk myometrium, health disparity, mechanotransduction, leiomyomas, uterine fibroid risk
Plan
| The authors report no conflict of interest. This work was supported by National Institutes of Health (NIH) grants RO1 HD094378, RO1 ES028615, and U54 MD007602. NIH had no role in the study design; conduction of the study; collection, analysis, and interpretation of data; or manuscript writing. |
|
| Part of this study was presented in the 77th American Society for Reproductive Medicine Scientific Congress & Expo, Baltimore, MD, US, Oct. 16–20, 2021 and in the 70th Annual Meeting of the Society of Reproductive Investigation, Brisbane, QLD, Australia, Mar. 21–25, 2023. |
|
| Cite this article as: Bariani MV, Grimm SL, Coarfa C, et al. Altered extracellular matrix–related pathways accelerate the transition from normal to prefibroid myometrium in Black women. Am J Obstet Gynecol 2024;231:324.e1-12. |
Vol 231 - N° 3
P. 324.e1-324.e12 - septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
